Xcelerate Inc.

Equities

XCRT

US98401T1051

Healthcare Facilities & Services

Market Closed - OTC Markets Other stock markets 17:08:24 15/05/2024 BST			5-day change	1st Jan Change
0.0341 ^USD	-5.13%		-10.26%	-5.28%

04-29	Xcelerate Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Xcelerate Inc. has filed an IPO in the amount of $17.25 million.	CI

Xcelerate Inc. Appoints Vincent C. du Vigneaud, to the Advisory Board

April 27, 2021 at 01:10 pm

Xcelerate Inc. announced Vincent C. du Vigneaud has joined its Advisory Board. du Vigneaud currently serves as Portfolio Manager/Analyst/Trader and Head of Non-Standard Investments FinTrust Capital Advisors in Greenville, SC. Prior to joining FinTrust Vincent held various trading /operations positions with several fund management firms and co-founded SuNOVA Capital and Thesis Fund Management, both New York-based hedge funds.

Latest news about Xcelerate Inc.

Xcelerate Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-29	CI
Xcelerate Inc. has filed an IPO in the amount of $17.25 million.	11-13	CI
Xcelerate Inc. Announces Publication of Its Two Utility Patent Applications	24/10/23	CI
Xcelerate Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	22/09/23	CI
Xcelerate Announces Marketing Agreement with ProductSector, LLC	08/08/23	CI
Xcelerate Inc. acquired a 51% stake in California Skin Research, Inc. from subscribing for shares and purchasing shares from two of the former principals.	23/07/23	CI
Xcelerate Inc. completed the acquisition of an unknown majority stake in ESN Group, Inc.	19/07/23	CI
Xcelerate Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	28/04/23	CI
Xcelerate Inc. Auditor Raises 'Going Concern' Doubt	27/04/23	CI
Xcelerate, Inc. Announces That Fabian Urquijo Has Accepted an Invitation to Join Its Xcelerate Brands Advisory Board	01/02/23	CI
Xcelerate Inc. entered into a letter of intent to acquire an unknown majority stake in ESN Group, Inc.	16/01/23	CI
Xcelerate Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	15/09/22	CI
Fran White Joins the Advisory Board of Xcelerate, Inc	15/02/22	CI
Xcelerate Inc. signed a Membership Interest Purchase Agreement to acquire a 51% interest in AfiyaSasa Africa, LLC.	02/01/22	CI
Xcelerate Inc. signed a non-binding letter of intent to acquire HS Pharmaceuticals, LLC.	05/05/21	CI
Xcelerate Inc. Appoints Vincent C. du Vigneaud, to the Advisory Board	27/04/21	CI
Union Dental Holdings Inc. has Changed its Name to Xcelerate, Inc	17/03/21	CI
Xcelerate, Inc Appoints Barry James Marshall to its Advisory Board	23/02/21	CI
Xcelerate, Inc. Appoints Dilantha B. Ellegala to the Advisory Board	08/02/21	CI
Union Dental Holdings, Inc. Announces Preliminary Agreement for Medical Patent	11/09/20	CI
Union Dental Holdings, Inc. Names Dr. Anja Glisovic as Chief Science Officer	04/09/20	CI
Union Dental Holdings Appoints Jason Householder as Board of Directors	04/08/20	CI
Union Dental Holdings Announces Steve Gravely as Board Member	23/07/20	CI
Union Dental Holdings Appoints Michael F. O’Shea as Interim President and Sole Director	16/07/20	CI
Union Dental Holdings Inc. cancelled the acquisition of remaining stake in Drinkable Air, Inc.	18/12/15	CI

Chart Xcelerate Inc.

Duration

Period

More charts

Company Profile

Xcelerate, Inc. seeks to acquire technology/healthcare business. The Companyâs business plan encompasses three separate but related businesses within the medical, health and wellness sectors, including owning and licensing the rights to various forms of medical equipment and portfolio of patents, patents pending and technology licenses; formulation, packaging and marketing of over the counter, clinically tested skin care products, and development of virtual health technology to assist patients in developing countries, initially in Africa, to provide for their population to obtain medical care by extending the reach of physicians through the use of that technology.

Sector

Healthcare Facilities & Services

More about the company

Income Statement Evolution

More financial data

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
XCELERATE INC.	-5.28%	14.8M
HCA HEALTHCARE, INC.	+20.79%	85.64B
CVS HEALTH CORPORATION	-28.75%	70.63B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+3.52%	27.05B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-6.19%	17.97B
FRESENIUS SE & CO. KGAA	+1.78%	17.58B
QUEST DIAGNOSTICS INCORPORATED	+2.10%	15.64B
REDE D'OR SÃO LUIZ S.A.	+7.06%	13.55B
FRESENIUS MEDICAL CARE AG	+10.01%	13.41B
NATERA, INC.	+71.31%	13.18B

Other Healthcare Facilities & Services